Literature DB >> 6209506

Changes in blood pressure and plasma catecholamines caused by tyramine and cold exposure.

A J Scriven, M J Brown, M B Murphy, C T Dollery.   

Abstract

Tyramine may be used to stimulate release of endogenous norepinephrine. We have compared the increases in blood pressure and plasma catecholamines in normal volunteers during (a) tyramine infusions, and (b) the more physiological sympathetic stimulus of cold exposure. In a second study, the cardiac component of the pressor effect of tyramine was assessed by measuring systolic time intervals, and by infusing tyramine in beta-blocked subjects. Tyramine, 15.0 micrograms/kg/min for 30 min, elevated systolic BP from 122 +/- 11 to 149 +/- 4 mm Hg, without increasing diastolic BP or heart rate. Plasma norepinephrine rose from 0.547 +/- 0.184 to 0.836 +/- 0.096 ng/ml; plasma epinephrine was unchanged. Thirty-min exposure to 4 degrees C elevated both systolic BP (from 105 +/- 8 to 116 +/- 9 mm Hg) and diastolic BP (from 72 +/- 4 to 81 +/- 6 mm Hg). This was associated with a greater rise in plasma norepinephrine, from 0.357 +/- 0.131 to 1.143 +/- 0.393 ng/ml; plasma epinephrine was again unchanged. A single oral dose of propranolol 160 mg caused approximately a two-fold right shift in the systolic BP dose response to tyramine, and blocked the tyramine-induced shortening of the presystolic ejection period. Tyramine appears to exert its pressor effect mainly by stimulation of cardiac beta-receptors. This may account for the relatively small rise in plasma norepinephrine (relative to cold exposure) since the heart does not contribute a high proportion of circulating norepinephrine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6209506     DOI: 10.1097/00005344-198409000-00033

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  9 in total

Review 1.  Evidence based treatment of hypertension. Measurement of blood pressure: an evidence based review.

Authors:  F A McAlister; S E Straus
Journal:  BMJ       Date:  2001-04-14

2.  Changes in blood pressure, body weight and urinary catecholamines during austerities.

Authors:  K Hashimoto; Y Aizawa; K Mori
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1987

3.  Responses of sympathetic nervous system to cold exposure in vibration syndrome subjects and age-matched healthy controls.

Authors:  M Nakamoto
Journal:  Int Arch Occup Environ Health       Date:  1990       Impact factor: 3.015

4.  Beta-blockade antagonism of tyramine-induced rise in blood pressure.

Authors:  F Colombo; R Sega; F Mailland; R Rigo; L Palvarini; A Libretti
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  The effect of angiotensin II on haemodynamic and plasma noradrenaline responses to tyramine infusion in man.

Authors:  P H Seidelin; A D Struthers
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 6.  Sources of inaccuracy in the measurement of adult patients' resting blood pressure in clinical settings: a systematic review.

Authors:  Noa Kallioinen; Andrew Hill; Mark S Horswill; Helen E Ward; Marcus O Watson
Journal:  J Hypertens       Date:  2017-03       Impact factor: 4.844

7.  Effects of cold air on cardiovascular disease risk factors in rat.

Authors:  Bin Luo; Shuyu Zhang; Shoucun Ma; Ji Zhou; Baojian Wang
Journal:  Int J Environ Res Public Health       Date:  2012-06-29       Impact factor: 3.390

8.  The cooling effect on proinflammatory cytokines interferon-gamma, tumor necrosis factor-alpha, and nitric oxide in patients with multiple sclerosis.

Authors:  Turan Poyraz; Egemen Idiman; Sezer Uysal; Leyla Iyilikci; Serkan Ozakbaş; Esra Coskuner Poyraz; Fethi Idiman
Journal:  ISRN Neurol       Date:  2013-05-16

9.  Effects of moderate strength cold air exposure on blood pressure and biochemical indicators among cardiovascular and cerebrovascular patients.

Authors:  Xiakun Zhang; Shuyu Zhang; Chunling Wang; Baojian Wang; Pinwen Guo
Journal:  Int J Environ Res Public Health       Date:  2014-02-27       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.